An optimal method of hydrogel spacer insertion for stereotactic body radiation therapy of prostate cancer
- 7 November 2023
- journal article
- research article
- Published by Springer Nature in Japanese Journal of Radiology
- Vol. 42 (4) , 406-414
Abstract
Purpose This study aimed to explore an ideal method for hydrogel spacer insertion by analyzing the efficacy and safety of our originally developed apex expansion method. Materials and methods Overall, 100 patients with low- and intermediate-risk localized prostate cancer treated with stereotactic body radiation therapy were included. A hydrogel spacer was inserted in 64 and 36 patients using the conventional and apex expansion methods, respectively. For dosimetry, we trisected the rectum into the upper rectum, middle rectum, and lower rectum on the sagittal section of magnetic resonance imaging. We compared the dose to each part of the rectum between the two methods using dose-volume histograms. Genitourinary and gastrointestinal toxicity assessments were conducted until 3 months of follow-up. Results The whole rectal dose in the apex expansion method group was lower than that in the conventional method group, which was significant in all dose regions (V5–V35). Similarly, in the apex expansion method group, the dose to the middle rectum was lower in the low- to high-dose region (V10–V35), and the dose to the lower rectum was lower in the middle- to high-dose region (V15–35). No Grade ≥ 3 toxicity or procedure-related complications were observed. Additionally, Grade 2 genitourinary and gastrointestinal toxicities during the treatment showed no significant differences between the two methods. Conclusion The apex expansion method may be safe and effective in achieving a more efficient rectal dose reduction by expanding the anterior perirectal space in the prostatic apex area.Keywords
This publication has 19 references indexed in Scilit:
- Multicenter Trial of Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer: Survival and Toxicity EndpointsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2018
- A multi-institutional phase 2 trial of prostate stereotactic body radiation therapy (SBRT) using continuous real-time evaluation of prostate motion with patient-reported quality of lifePractical Radiation Oncology, 2018
- Hydrogel spacer distribution within the perirectal space in patients undergoing radiotherapy for prostate cancer: Impact of spacer symmetry on rectal dose reduction and the clinical consequences of hydrogel infiltration into the rectal wallPractical Radiation Oncology, 2017
- Continued Benefit to Rectal Separation for Prostate Radiation Therapy: Final Results of a Phase III TrialInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2017
- Stereotactic body radiation therapy for low and intermediate risk prostate cancer—Results from a multi-institutional clinical trialEuropean Journal of Cancer, 2016
- Hydrogel Spacer Prospective Multicenter Randomized Controlled Pivotal Trial: Dosimetric and Clinical Effects of Perirectal Spacer Application in Men Undergoing Prostate Image Guided Intensity Modulated Radiation TherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2015
- Learning Curve in the Application of a Hydrogel Spacer to Protect the Rectal Wall During Radiotherapy of Localized Prostate CancerUrology, 2013
- Meta-analysis of the Alpha/Beta Ratio for Prostate Cancer in the Presence of an Overall Time Factor: Bad News, Good News, or No News?International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2013
- American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) Practice Guideline for the Performance of Stereotactic Body Radiation TherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreasCancer, 2009